Clinical trials of chimeric antigen receptor T‐cell (CAR‐T) therapies in glioblastoma have shown limited clinical benefits. Whether this may be explained by the basal quality of CAR‐T products, which are currently generated using patient, autologous T‐cells, has been little explored.
Sabra K. Salim +22 more
wiley +1 more source
Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies
Ocular abnormal angiogenesis and edema are featured in several ocular diseases. S1P signaling via S1P1 likely is part of the negative feedback mechanism necessary to maintain vascular health.
Shinsuke Nakamura +11 more
doaj +1 more source
Pharmacological blockade of G-protein coupled receptors : interventions to alter expression or internalization [PDF]
Hangartner, Christoph
core +1 more source
Safety, pharmacokinetics and pharmacodynamics of NXC736, a novel sphingosine-1-phosphate receptor modulator. [PDF]
Chung WK +5 more
europepmc +1 more source
Sphingosine-1-Phosphate Receptor 1 Regulates Competition Dependent Astrocyte Morphogenesis and Tiling in Murine Cortex. [PDF]
Gonzales JPM +9 more
europepmc +1 more source
Fungal Infections Associated with Sphingosine 1-Phosphate Receptor Modulators: Immunological Mechanisms, Clinical Patterns, and Management Considerations. [PDF]
Yazdan KM, Madam ST, Pasula S.
europepmc +1 more source
Correction: Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies. [PDF]
Nakamura S +11 more
europepmc +1 more source
Effects of sphingosine-1-phosphate receptor modulators on remyelination in multiple sclerosis: evidence from <i>in vitro</i> experiments, animal models and human studies. [PDF]
Ricigliano VAG.
europepmc +1 more source
Sphingosine-1-phosphate receptor 1 signaling stimulates human pluripotent stem cell-derived cardiomyocyte differentiation and maturation. [PDF]
Yu WD +14 more
europepmc +1 more source

